Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Syngene International Ltd

NSE: SYNGENE · BSE: 539268 · Pharmaceuticals & Biotechnology · 38 announcements

Share price
₹360.30
Market cap
₹14,544 Cr
Revenue (annual)
₹3,739 Cr
Net profit (annual)
₹316.7 Cr
P/E (TTM)
65.8×Sector 47.3×
Promoter holding
52.59%-0.09% QoQ
FII holding
11.82%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:07 IST NSE
Merger & Restructuring

Syngene International Merger & Restructuring

Syngene International Limited announced the voluntary liquidation of its wholly owned subsidiary. The closure streamlines the company's corporate structure and has no material financial impact.

22:43 IST NSE
Merger & Restructuring

Syngene International Merger & Restructuring Worth ₹0.94 Cr

Syngene approved the voluntary liquidation of its non-operational subsidiary, SMSL. The move streamlines corporate structure without impacting consolidated financial performance.

Value
₹0.94 Cr